Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
AE leading to drug discontinuation were observed in 16% of participants with the 12 mg dose, but the overall incidence of SAE was low (up to 6-8%)
Step 3: Factor Analysis: After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the GLP-1 Analogues market
The Chinese government's 14th Five-Year Plan for healthcare specifically identifies diabetes management as a chronic disease prevention priority, with investment in guideline-based pharmacotherapy programs that are driving adoption of evidence-based GLP-1 therapy in public healthcare settings Middle East & Africa and Latin America GLP-1 Receptor Agonist Market Insights The Middle East represents a commercially interesting GLP-1 market because the Gulf states combine high rates of type 2 diabetes and obesity the UAE's adult obesity rate exceeds 37%, among the world's highest with high-income consumer populations and expanding private health insurance coverage
FDA-approved oral GLP-1 tablets Rybelsus is the most well-known FDA-approved oral semaglutide
US$ 24.59
US$ 21.42
US$ 23.20
